News

Investor News from Reuters

November 30, 2016 - REUTERS

Delcath Systems to Present at the 9th Annual LD Micro Main Event

November 11, 2016 - REUTERS

Delcath Announces Third Quarter Financial Results

October 18, 2016 - REUTERS

Delcath Issues Letter to Stockholders

October 17, 2016 - REUTERS

Review Of Delcath's CHEMOSAT Accepted For Publication In Advances In Therapy

October 12, 2016 - REUTERS

Delcath Announces First European Clinical Sites For FOCUS Phase 3 Trial For Ocular Melanoma Liver Metastases

October 11, 2016 - REUTERS

Delcath Announces New U.S. Clinical Sites For FOCUS Phase 3 Trial For Ocular Melanoma Liver Metastases

October 05, 2016 - REUTERS

Delcath To Present At The Dawson James Securities Growth Stock Conference

September 30, 2016 - REUTERS

Delcath Prices Underwritten Public Offering of Common Stock and Warrants

September 29, 2016 - REUTERS

Delcath Announces Proposed Public Offering of Common Stock and Warrants

September 19, 2016 - REUTERS

Delcath Sponsors Ocular Melanoma Foundation Patient Retreat

September 14, 2016 - REUTERS

Data Supporting CHEMOSAT Presented at the Cardiovascular and Interventional Radiology Society of Europe Conference

September 12, 2016 - REUTERS

Delcath To Present At The 2016 Aegis Growth Conference

September 12, 2016 - REUTERS

Researchers at leiden univeristy medical center receive outstanding service award for Publication on Delcath's Melphalan/HDS

August 16, 2016 - REUTERS

Delcath Announces Second Quarter Financial Results

July 18, 2016 - REUTERS

Delcath Announces Acceptance Of Abstracts For Poster Presentation At CIRSE 2016

July 07, 2016 - REUTERS

Outcomes Study On Delcath's Melphalan/HDS In The Treatment Of Hepatic Metastases To Be Published In Cancer Control

July 06, 2016 - REUTERS

European Data Supporting Survival Benefit With Delcath's CHEMOSAT System Presented At 6th European Post-Chicago Melanoma/Skin Cancer Meeting

June 23, 2016 - REUTERS

Delcath European Patient Education Website Receives Prestigious Digital Health Award

June 15, 2016 - REUTERS

Delcath Announces Acceptance Of Abstract For Presentation At 6th European Post-Chicago Melanoma/Skin Cancer Meeting

June 07, 2016 - REUTERS

Delcath Issues $35 Million in Senior Convertible Notes to Support Melphalan/HDS Clinical Development and CHEMOSAT European Commercialization

June 01, 2016 - REUTERS

Delcath Announces Launch of CHEMOSAT at the HM Sanchinarro University Hospital in Madrid

May 31, 2016 - REUTERS

Delcath to Present at the 6th Annual LD Micro Invitational

May 04, 2016 - REUTERS

Delcath Announces First Quarter Financial Results

May 03, 2016 - REUTERS

Leading U.S. Cancer Centers Join Delcath's Focus Phase 3 Trial For Patients With Hepatic Dominant Ocular Melanoma

April 08, 2016 - REUTERS

Delcath Announces First CHEMOSAT® Procedures In Turkey

March 21, 2016 - REUTERS

Delcath Announces 2015 Fourth Quarter and Full Year Financial Results

March 07, 2016 - REUTERS

Delcath to Present at the 28th Annual ROTH Conference

February 11, 2016 - REUTERS

Delcath announces Engagement of Lars E. Birgerson, M.D., Ph. D as global medical consultant

February 10, 2016 - REUTERS

Delcath Announces Beginning Of Patient Enrollment In Phase 3 Focus Trial

February 04, 2016 - REUTERS

Delcath Systems to Present at Upcoming Investor Conferences

January 20, 2016 - REUTERS

Delcath Announces Initiation Of Phase 3 Trial Of Melphalan/HDS System For Treatment Of Hepatic Dominant Ocular Melanoma

January 19, 2016 - REUTERS

Delcath Announces Special Protocol Assessment Agreement With FDA For New Phase 3 Trial In Hepatic Dominant Ocular Melanoma

January 15, 2016 - REUTERS

Delcath To Present At NobleCon12 Investor Conference

January 11, 2016 - REUTERS

Review of Delcath Melphalan/HDS System Published in "Cardiovascular & Interventional Radiology"